Ceftaroline fosamil
Teflaro, Zinforo (ceftaroline fosamil) is a small molecule pharmaceutical. Ceftaroline fosamil was first approved as Teflaro on 2010-10-29. It is used to treat escherichia coli infections, infectious skin diseases, klebsiella infections, pneumonia, and staphylococcal infections amongst others in the USA. It has been approved in Europe to treat community-acquired infections, infectious skin diseases, and pneumonia. Teflaro's patents are valid until 2031-02-10 (FDA).
| Trade Name | Zinforo |
|---|---|
| Common Name | Ceftaroline fosamil |
| Indication | community-acquired infections, escherichia coli infections, infectious skin diseases, klebsiella infections, pneumonia, staphylococcal infections, streptococcal infections |
| Drug Class | Cephalosporins; phosphoro-derivatives |
